Cargando…
Key concepts in biosimilar medicines: What physicians must know
Biologics’ are a class of medications produced by living cells using recombinant DNA technology. Biologics have had an important impact in many areas of medicine, and in particular in rheumatology and oncology. However, the high cost of these agents is a growing concern, particularly as more product...
Autor principal: | Iskit, Alper B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Health Directorate of Istanbul
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889217/ https://www.ncbi.nlm.nih.gov/pubmed/35340312 http://dx.doi.org/10.14744/nci.2021.84669 |
Ejemplares similares
-
Use of Herbal Medicine by Pregnant Women: What Physicians Need to Know
por: Illamola, Sílvia M., et al.
Publicado: (2020) -
Imaging Spectrum in Coronavirus Disease-2019: What Every Nuclear Medicine Physician Must Know?
por: D’Souza, Maria Mathew, et al.
Publicado: (2020) -
Methemoglobinemia: What the anaesthetist must know
por: Tandale, Sushama, et al.
Publicado: (2013) -
Biosimilar Insulins – What a Clinician Needs to Know?
por: Ghosh, Sujoy, et al.
Publicado: (2019) -
Critical fail concepts in surgery: highlighting the “must-know” concepts
por: Abdalkhani, Arman, et al.
Publicado: (2021)